Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAclvEZzHRBQlKCW3XKvzCMuoTrFu73meKoPXJdW008Pk#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _5 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _5 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _4 provenance.
- assertion hadPrimarySource 14657001 provenance.
- _4 wasQuotedFrom 14657001 provenance.
- _4 value "Successful treatment of established human tumors, however, might require not only prevention of further angiogenesis but also destruction of already existing tumor blood vessels to reduce the already existing tumor mass. In line with this, VEGF has been shown to not only act as an angiogenic factor but also as a survival factor for endothelial cells and newly formed blood vessels. In the developing retina, hyperoxia-induced vessel regression has been correlated with inhibition of glial VEGF release (5)." provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.